Foghorn Therapeutics competitorsClear all

Foghorn Therapeutics's top competitors include Nurix, Kymera Therapeutics, Arvinas and Ultivue.

Save Comparison	Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.	Nurix Nurix, Inc. is a leader in discovering and developing a new class of drugs that work by modulating the protein regulation machinery of the cell.	Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.	Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.	Ultivue Ultivue operates in the biotechnology industry.
Founding Date	Founding Date 2016	Founding Date 2009	Founding Date 2017	Founding Date N/A	Founding Date 2015
Type	Type Public	Type Private	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech	Tags Healthcare biotech drug development therapy	Tags Healthcare Technology drug development oncology pharma platform therapy	Tags Healthcare biotech chemicals
Locations	Locations Cambridge, US HQ	Locations San Francisco, US HQ	Locations Cambridge, US HQ	Locations New Haven, US HQ	Locations Cambridge, US HQ Segrate, IT
Employees	Employees 85	Employees 1251% increase	Employees 685% increase	Employees 13329% increase	Employees 609% increase
Valuation ($)	Valuation ($) 707.5 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 947.2 m	Valuation ($) N/A
Twitter followers	Twitter followers 507	Twitter followers N/A	Twitter followers 1.7 k	Twitter followers 1.6 k	Twitter followers 275
Number of tweets (last 30 days)	Number of tweets (last 30 days) 1	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 13	Number of tweets (last 30 days) 20	Number of tweets (last 30 days) 2
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 1	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 7.9	Average likes per tweet (last 30 days) 3.6	Average likes per tweet (last 30 days) 2
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 92.31%	Percentage of tweets with engagement (last 30 days) 90%	Percentage of tweets with engagement (last 30 days) 100%
Alexa Website Rank	Alexa Website Rank 320003	Alexa Website Rank 414673	Alexa Website Rank 400507	Alexa Website Rank 332663	Alexa Website Rank 420838
Employee Rating	Employee Rating N/A	Employee Rating 3.8	Employee Rating N/A	Employee Rating 5	Employee Rating 3.5
Financial
Net income	Net income ($51.1m) (FY, 2019)	Net income N/A	Net income N/A	Net income ($70.3m) (FY, 2019)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 120m (9 months ago)	Latest funding round $ 102m (9 months ago)	Latest funding round N/A	Latest funding round $ 22m (over 1 year ago)
Total funding raised	Total funding raised $ 50m	Total funding raised $ 165.2m	Total funding raised $ 197m	Total funding raised $ 111.6m	Total funding raised $ 57.3m